REFERENCES
- Mustard JF, Packham MA, Rowsell HC, et al: The role of thrombogenic factors in atherosclerosis. Ann NY Acad Sci 149:848–859, 1968
- Edwards JE: Pathologic spectrum of occlusive coronary arterial disease. Lab Invest 5:475–491, 1956
- Mann FD: A simple rule for control of anticoagulant therapy. Postgrad Med 44:55–57, Oct 1968
- Singer JW, Sibley CA: Sensitivity of commercial thromboplastins to factor VII. Am J Clin Pathol 59:755–759, 1973
- Loeliger EA: Progress in the control of oral anticoagulation. Thromb Diath Haemorrh 28:109–119, 1972
- Thomes AB, Scallen RW, Savage IR: The prophylactic value of long term anticoagulant therapy. Circulation 21:354–362, 1960
- Block WJ Jr, Mann FD, Barker NW: Effect of small doses of heparin in increasing translucence of plasma during alimentary lipemia: Studies in normal individuals and patients with atherosclerosis. Circulation 4:674–678, 1951
- Porte D Jr, Bierman EL: The effect of heparin infusion on plasma triglyceride in vivo and in vitro with a method for calculating triglyceride turnover. J Lab Clin Med 73:631–648, 1969
- Pilgeram LO: Turnover rate of autologous plasma fibrinogen-14C in subjects with coronary thrombosis. Thromb Diath Haemorrh 20:31–43, 1968